Key points are not available for this paper at this time.
Abstract Background: The goal of this study is to assess whether an online, virtual patient simulation (VPS) continuing medical educational (CME) activity, improved the performance of oncologists in ordering appropriate diagnostic tests and managing and counselling patients with HR+/HER2- early breast cancer (EBC) at high risk of recurrence. Methods: Two VPS educational activities were developed, the first VPS consisted of one patient case, focused on diagnosing patients with high risk of recurrence, while the other VPS consisted of 2 patient cases focused on the management and counselling of patients with HR+/HER2- EBC with high risk of recurrence. Physicians could make clinical decisions using complete open-field entries, based on the 3 performance based learning objectives. After each decision, learners received clinical guidance (CG) based on current evidence and expert recommendations. Pre- and post-CG clinical decisions were compared using a a McNemar's test to determine P values (P .05 is significant). Rationales for clinical decisions were collected in real time. Data were collected between November 2021 and August 2022 and are reported here as % point change per performance learning objective, P value. Results: A total of 922 oncologists were included in the analysis. There was a significant improvement across the 3 performance learning objectives analysed. Please see table below for the results. Conclusions: This analysis demonstrated the educational impact of an immersive, online VPS education which allowed physicians to improve evidence-based clinical decisions regarding diagnosing patients with HR+/HER2- early breast cancer at high risk of recurrence and managing and counselling them regarding their treatment. Results Citation Format: Nabil Dorkhom, Urvi Patel, Stephanie Baumhover, Jacob Cohen. Online Virtual Patient Simulation CME Improves Clinical Decision-Making In The Management Of Patients With HR+/HER2- Early Breast Cancer abstract. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl):Abstract nr PO2-02-01.
Dorkhom et al. (Thu,) studied this question.